Prism Medico & Pharmacy
add_icon

Prism Medico & Pharmacy

27.40
+1.02
(3.87%)
Market Cap
16.62 Cr
PE Ratio
26.65
Volume
11,628.00
Day High - Low
27.40 - 25.68
52W High-Low
30.22 - 12.07
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
16.62 Cr
EPS
0.07
PE Ratio
26.65
PB Ratio
1.06
Book Value
24.89
EBITDA
0.40
Dividend Yield
0.00 %
Sector
NBFC
Return on Equity
0.31
Debt to Equity
0.17
Forecast For
Actual

Company News

View All News
Caret
neutral
Prism Medico and Pharmacy Limited informs stock exchanges that no non-convertible securities with payable interest/dividend/principal amounts exist for Q1 FY27 period.
neutral
Prism Medico and Pharmacy Limited attributes recent stock price movements to market conditions and speculation, confirming all material information has been disclosed as per SEBI regulations.
positive
Prism Medico and Pharmacy Limited submitted scrutinizer's report showing 99.98% approval for both special resolutions on Articles amendment and preferential issue at March 20, 2026 EGM.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
826.85
#1 5,14,505.91
27.75
#1 69,724.80
26.81
#1 16,780
-5.62
38.68
891.60
1,67,760.37
18.52
41,859.50
19.61
9,423
-22.13
39.45
229.48
1,45,791.89
91.70
2,078.90
12.09
1,613
-8.75
41.17
3,178.80
1,27,618.80
15.10
20,324.50
34.04
5,352
102.90
42.46
1,356.30
1,15,536.37
24.13
26,152.80
34.67
4,260
18.54
31.07
638.20
60,730.78
28.99
18,637.10
6.60
1,916
45.25
31.42
4,538.00
50,418.93
24.78
8,563.00
17.53
1,813
18.86
36.89
285.15
39,635.03
16.93
18,530.50
16.03
2,261
-10.03
31.12
419.70
35,641.99
#1 10.10
4,612.20
#1 76.63
4,241
-70.06
38.80
393.30
31,966.98
89.02
4,222.80
34.17
-98
#1 703.21
43.67
Growth Rate
Revenue Growth
139.91 %
Net Income Growth
-
Cash Flow Change
-112.39 %
ROE
-1,133.33 %
ROCE
-97.09 %
EBITDA Margin (Avg.)
-79.55 %

Quarterly Financial Results

Quarterly Financials
Mar 2016
Jun 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Revenue
0
0
3
12
6
5
0
6
15
17
17
9
7
10
Expenses
0
0
2
11
6
5
1
5
15
17
17
9
6
10
EBITDA
0
-0
1
1
0
0
-0
1
0
0
-1
0
0
0
Operating Profit %
0 %
0 %
26 %
7 %
1 %
1 %
-50 %
7 %
2 %
1 %
-5 %
2 %
3 %
0 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
-0
1
1
-0
-0
-0
0
0
0
-1
0
0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
0
-0
1
1
-0
-0
-0
0
0
0
-1
0
0
0
EPS in ₹
0.00
-0.53
0.90
1.12
-0.23
-0.19
-0.70
0.62
0.46
0.24
-1.21
0.21
0.15
-0.07

Balance Sheet

Balance Sheet
2017
2018
2019
Total Assets
17
16
21
Fixed Assets
10
9
9
Current Assets
7
4
11
Capital Work in Progress
0
0
0
Investments
0
3
1
Other Assets
7
4
11
Total Equity & Liabilities
17
16
21
Current Liabilities
1
3
8
Non Current Liabilities
3
0
0
Total Equity
13
13
13
Reserve & Surplus
7
7
7
Share Capital
6
6
6

Cash Flow

Cash Flow
2017
2018
2019
Net Cash Flow
0
-1
-1
Investing Activities
0
-3
0
Operating Activities
0
4
-0
Financing Activities
0
-2
-1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
38.02 %
29.06 %
23.93 %
23.93 %
23.93 %
23.93 %
23.93 %
23.93 %
23.93 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
54.60 %
59.85 %
69.11 %
68.82 %
67.22 %
67.65 %
64.91 %
64.89 %
61.78 %
63.66 %
64.02 %
65.76 %
67.23 %
67.30 %
65.77 %
65.36 %
66.07 %
65.26 %
65.26 %
65.63 %
Others
7.38 %
11.09 %
6.95 %
7.25 %
8.85 %
8.42 %
11.16 %
11.18 %
14.29 %
11.34 %
10.98 %
9.24 %
7.77 %
7.70 %
9.23 %
9.64 %
8.93 %
9.74 %
9.74 %
9.37 %
No of Share Holders
1,243
1,900
2,790
3,731
4,245
4,168
3,890
3,328
3,558
3,610
3,465
3,650
3,792
3,866
4,107
4,178
4,302
4,306
4,315
4,306

Announcements

Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.3 days ago
Closure of Trading Window3 days ago
Clarification With Respect To Significant Movement In The Price Of Our Security At The Stock Exchange.3 days ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report9 days ago
Regulation 30(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - Proceedings Of Extraordinary General Meeting Held On 20Th March 2026.Mar 20, 2026
Shareholder Meeting / Postal Ballot-Outcome of EGMMar 20, 2026
Publication Of Corrigendum To Notice To Shareholders.Mar 19, 2026
Intimation Regarding Record Date.Feb 26, 2026
Intimation Of Book Closure.Feb 26, 2026
Notice Of Extraordinary General Meeting.Feb 25, 2026
Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 23, 2026
Clarification sought from Prism Medico and Pharmacy LtdFeb 23, 2026
Board Meeting Intimation for Intimation Of Board Meeting.Feb 18, 2026
Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 13, 2026
Board Meeting Intimation for Consideration Approval And Taking On Record The Unaudited Standalone Financial Results Of The Company Along With The Limited Review Report For The Quarter Ended 31St December 2025.Feb 07, 2026
Undertaking Of Functional WebsiteJan 30, 2026
Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Jan 16, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2026
Compliance-57 (5) : intimation after the end of quarterJan 02, 2026
Intimation Under Regulation 57(4) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Dec 31, 2025
Closure of Trading WindowDec 24, 2025
Revised Outcome Of The Board Meeting Held On 14Th November 2025.Nov 21, 2025
Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Nov 14, 2025
Board Meeting Intimation for Intimation Of Board Meeting.Nov 06, 2025
Undertaking Of Functional Website.Oct 27, 2025
Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Oct 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Compliance-57 (5) : intimation after the end of quarterOct 01, 2025
Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Oct 01, 2025
Closure of Trading WindowOct 01, 2025
Regulation 30(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - Proceedings Of 23Rd Annual General Meeting Held On 30Th September 2025.Sep 30, 2025
Outcome Of 23Rd Annual General Meeting Held On 30Th September 2025 At 11:30 A.M. Through Video Conferencing/Other Audio Visual Means.Sep 30, 2025
Revised Outcome Of Board Meeting Dated 14Th August 2025.Sep 12, 2025
Reg. 34 (1) Annual Report.Sep 06, 2025
Intimation Of Record Date.Sep 05, 2025
Intimation Of Book Closure.Sep 05, 2025
Notice Of 23Rd Annual General Meeting.Sep 05, 2025
Annual Report For The Financial Year 2024-2025.Sep 05, 2025
Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Sep 05, 2025
Board Meeting Intimation for Intimation Of Board Meeting.Sep 01, 2025
Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 14, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesAug 07, 2025
Board Meeting Intimation for Meeting To Be Held On Thursday The 14Th Day Of August 2025 At 01:30 P.M. At The Registered Office Of The Company I.E. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030.Aug 07, 2025
Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 04, 2025
Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jul 16, 2025
Undertaking Of Functional Website.Jul 15, 2025
Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Jul 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Revised Outcome Of Board Meeting Dated 28Th May 2025.Jul 01, 2025

Technical Indicators

RSI(14)
Neutral
57.91
ATR(14)
Volatile
1.90
STOCH(9,6)
Neutral
45.44
STOCH RSI(14)
Neutral
29.61
MACD(12,26)
Bearish
-0.23
ADX(14)
Strong Trend
26.02
UO(9)
Bearish
56.41
ROC(12)
Uptrend And Accelerating
4.97
WillR(14)
Neutral
-45.65